Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

SELL
$129.87 - $162.82 $62,337 - $78,153
-480 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$106.71 - $143.18 $51,220 - $68,726
480 New
480 $262,000
Q3 2020

Nov 02, 2020

SELL
$95.51 - $112.95 $61,126 - $72,288
-640 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$62.68 - $105.34 $40,115 - $67,417
640 New
640 $259,000
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $88,411 - $139,915
-1,850 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $67,747 - $105,986
1,850 New
1,850 $405,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Asahi Life Asset Management Co., Ltd. Portfolio

Follow Asahi Life Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.